Patel, N. A. Et Al. 2023. Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity: A Multicenter Study. Ophthalmology , vol.130, no.4 , 373-378.

Patel, N. A., Acaba-Berrocal, L. A., Hoyek, S., Fan, K. C., Martinez-Castellanos, M. A., Baumal, C. R., ... Harper, C. A.(2023). Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity: A Multicenter Study. Ophthalmology , vol.130, no.4, 373-378.

Patel, Nimesh Et Al. "Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity: A Multicenter Study," Ophthalmology , vol.130, no.4, 373-378, 2023

Patel, Nimesh A. Et Al. "Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity: A Multicenter Study." Ophthalmology , vol.130, no.4, pp.373-378, 2023

Patel, N. A. Et Al. (2023) . "Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity: A Multicenter Study." Ophthalmology , vol.130, no.4, pp.373-378.

@article{article, author={Nimesh A. Patel Et Al. }, title={Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity: A Multicenter Study}, journal={Ophthalmology}, year=2023, pages={373-378} }